Search Results 1751-1760 of 16124 for Epilepsy (Partial Onset)

1. Recovery of Left Ventricular Systolic Function and Atrial Fibrillation Recurrence after Restoration of Sinus Rhythm in Patients with Atrial Fibrillation - Mayo Clinic

   Participation eligibility · Age more than 18 years · Non-valvular atrial fibrillation · AF of <12 months duration.

2. An Open-label Study to Assess the Anti-Tumor Activity and Safety of REGN1979, an Anti-CD20 X Anti-CD3 Bispecific Antibody, in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma - Mayo Clinic

   Patients with a history seizure ... The reliability of sexual abstinence needs to be evaluated in relation to the duration of the clinical trial and the preferred ...

3. Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD) - Mayo Clinic

   discontinuing study drug. 4. Males with a partner of childbearing potential must agree to use a barrier method (condom) with a spermicide for the duration of ...

4. An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) (VALOR (Part C)) - Mayo Clinic

   An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) (VALOR ( ...

5. Light Treatment Effectiveness (LITE) Study (LITE) - Mayo Clinic

   The purpose of this study is to compare the effectiveness, safety (tolerability), and duration of treatment response at 12 weeks of home versus office-based ...

6. Noninterventional Study Evaluating Parkinson's Disease Diary Use - Mayo Clinic

   Diagnosis of primary mitochondrial disorder, epilepsy, stroke, multiple sclerosis, or clinical features suggestive of a neurodegenerative disease other than PD ...

7. A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgitation Subjects Receiving the MitraClip® Device - Mayo Clinic

   Subject must not have any disabilities that preclude reliable data collection from the Actiwatch, e.g., epilepsy with uncontrolled recurring episodes ...

8. Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed By Surgery - Mayo Clinic

   ... duration of study participation; should a woman become pregnant or suspect she is pregnant while she or her partner is participating in this study, she ...

9. A Study to Evaluate the Safety and Effectiveness of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD) - Mayo Clinic

   ... duration of study treatment and for 48 hours after discontinuing study drug. Subjects must have negative pregnancy tests at Screening Visit 1 (urine [prior ...

10. Pembrolizumab, Lenalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplant - Mayo Clinic

    This phase II trial studies how well pembrolizumab, lenalidomide, and dexamethasone work in treating patients with newly diagnosed multiple myeloma that are ...